Oliver Buck holds a graduate degree in theoretical physics (Biophysics) from the Technical University of Munich and is a serial entrepreneur with a long track-record in innovation, investment and the development of technology companies.
Throughout his entrepreneurial career Oliver has been involved in such diverse fields as information systems, defence and environmental technologies, construction, industrial engineering and – especially during the past decade – the targeted isotope therapy and precision oncology sector.
In 2004 he founded ITM Isotope Technologies Munich AG in collaboration with the Technical University of Munich. Subsequently the company developed into a global leader in next generation medical isotopes and theranostics. In 2012 he transitioned from his position as CEO of ITM AG to the supervisory board and continues to actively support ITM and its subsidiary companies in their strategic business development.
As of today Oliver Buck is actively involved in the development of a select group of portfolio companies as an Investor, Board Member and Advisor to the Executive Management, with an emphasis on innovation, strategic management and global business development.
Oliver is an alumnus of the German National Academy for Security Policy, the “Young Leaders Program” of the Atlantik Brücke /American Council on Germany, a founding member of Global Bridges e.V. and an alumnus of Singularity University.